O	0	6	Effect
O	7	9	of
B-intervention	10	17	Topical
I-intervention	18	28	Anesthetic
I-intervention	29	34	Cream
O	35	37	on
B-condition	38	42	Pain
O	43	49	During
O	50	61	Periareolar
O	62	71	Injection
O	72	74	of
O	75	85	Technetium
O	86	91	Tc99m
O	92	98	Sulfur
O	99	106	Colloid
O	107	110	for
O	111	119	Sentinel
O	120	125	Lymph
O	126	130	Node
O	131	137	Biopsy
O	138	140	in
O	141	147	Breast
O	148	154	Cancer
O	154	155	:
O	156	157	A
O	158	168	Randomized
O	169	176	Control
O	177	182	Trial
O	182	183	.

O	184	193	Injection
O	194	196	of
O	197	202	Tc99m
O	203	205	to
O	206	214	localize
O	215	220	nodes
O	221	224	for
O	225	233	sentinel
O	234	239	lymph
O	240	244	node
O	245	251	biopsy
O	252	254	is
O	255	263	reported
O	264	266	by
O	267	275	patients
O	276	278	as
O	279	283	very
O	284	291	painful
O	291	292	.

O	293	296	The
O	297	304	purpose
O	305	307	of
O	308	312	this
O	313	318	study
O	319	322	was
O	323	325	to
O	326	335	determine
O	336	338	if
O	339	349	anesthetic
O	350	355	cream
O	356	363	reduces
O	364	368	pain
O	369	379	associated
O	380	384	with
O	385	396	periareolar
O	397	406	injection
O	407	409	of
O	410	415	Tc99m
O	416	419	and
O	420	422	to
O	423	427	help
O	428	437	elucidate
O	438	449	conflicting
O	450	460	literature
O	461	470	regarding
O	471	474	the
O	475	483	efficacy
O	484	486	of
O	487	497	anesthetic
O	498	503	cream
O	504	507	for
O	508	512	this
O	513	522	procedure
O	522	523	.

O	524	525	A
O	526	536	randomized
O	536	537	,
O	538	544	double
O	544	545	-
O	545	550	blind
O	550	551	,
O	552	559	placebo
O	559	560	-
O	560	570	controlled
O	571	582	methodology
O	583	586	was
O	587	591	used
O	592	595	for
B-eligibility	596	601	adult
I-eligibility	602	609	females
I-eligibility	610	614	with
I-eligibility	615	621	breast
I-eligibility	622	628	cancer
I-eligibility	629	639	undergoing
I-eligibility	640	651	periareolar
I-eligibility	652	661	injection
I-eligibility	662	664	of
I-eligibility	665	670	Tc99m
I-eligibility	671	674	for
I-eligibility	675	683	sentinel
I-eligibility	684	689	lymph
I-eligibility	690	694	node
I-eligibility	695	701	biopsy
O	701	702	.

O	703	707	Pain
O	708	714	levels
O	715	719	were
O	720	728	compared
O	729	734	using
O	735	745	anesthetic
O	746	751	cream
O	752	753	(
O	753	754	2
O	754	755	.
O	755	756	5
O	756	757	%
O	758	767	lidocaine
O	767	768	/
O	768	769	2
O	769	770	.
O	770	771	5
O	771	772	%
O	773	783	prilocaine
O	783	784	)
O	785	787	vs
O	787	788	.
B-control	789	796	placebo
O	796	797	.

O	798	805	Patient
O	806	815	exclusion
O	816	824	criteria
O	825	833	included
O	834	837	use
O	838	840	of
O	841	848	opioids
O	849	851	or
O	852	860	adjuvant
O	861	865	pain
O	866	876	medication
O	877	879	or
O	880	889	injecting
O	890	895	Tc99m
O	896	899	the
O	900	903	day
O	904	910	before
O	911	918	surgery
O	918	919	.

O	920	923	The
O	924	933	Numerical
O	934	940	Rating
O	941	946	Scale
O	947	950	was
O	951	955	used
O	956	958	to
O	959	965	assess
O	966	970	pain
O	971	977	levels
O	978	989	immediately
O	990	995	after
O	996	999	the
O	1000	1010	injections
O	1010	1011	.

O	1012	1021	Comparing
B-intervention-participants	1022	1024	23
O	1025	1037	experimental
O	1038	1041	and
B-control-participants	1042	1044	26
O	1045	1052	control
O	1053	1061	patients
O	1061	1062	,
O	1063	1068	there
O	1069	1072	was
O	1073	1075	no
O	1076	1087	significant
O	1088	1098	difference
O	1099	1106	between
O	1107	1110	the
O	1111	1123	experimental
O	1124	1125	(
O	1125	1131	median
O	1132	1133	=
O	1134	1135	4
O	1135	1136	)
O	1137	1140	and
O	1141	1144	the
O	1145	1152	control
O	1153	1158	group
O	1159	1160	(
O	1160	1166	median
O	1167	1168	=
O	1169	1170	5
O	1170	1171	)
O	1172	1174	on
O	1175	1180	level
O	1181	1183	of
B-outcome	1184	1188	pain
I-outcome	1189	1200	experienced
O	1201	1202	U
O	1202	1203	=
O	1204	1205	0
O	1205	1206	.
O	1206	1209	492
O	1209	1210	,
O	1211	1212	P
O	1213	1214	>
O	1215	1216	.
O	1216	1218	05
O	1218	1219	.

O	1220	1223	The
O	1224	1236	experimental
O	1237	1242	group
O	1243	1246	had
O	1247	1248	a
O	1249	1257	slightly
O	1258	1263	lower
B-outcome	1264	1270	median
I-outcome	1271	1275	pain
I-outcome	1276	1281	score
O	1281	1282	;
O	1283	1290	however
O	1290	1291	,
O	1292	1297	there
O	1298	1301	was
O	1302	1304	no
O	1305	1318	statistically
O	1319	1330	significant
O	1331	1341	difference
O	1342	1349	between
O	1350	1355	those
O	1356	1359	who
O	1360	1364	used
O	1365	1368	the
O	1369	1374	cream
O	1375	1383	compared
O	1384	1388	with
O	1389	1394	those
O	1395	1398	who
O	1399	1403	used
O	1404	1405	a
O	1406	1413	placebo
O	1413	1414	,
O	1415	1425	supporting
O	1426	1429	the
O	1430	1440	conclusion
O	1441	1445	that
O	1446	1456	anesthetic
O	1457	1462	cream
O	1463	1467	does
O	1468	1471	not
O	1472	1478	reduce
O	1479	1483	pain
O	1484	1490	during
O	1491	1496	Tc99m
O	1497	1507	injections
O	1507	1508	.

O	1509	1513	This
O	1514	1519	study
O	1520	1524	adds
O	1525	1527	to
O	1528	1531	the
O	1532	1539	current
O	1540	1550	literature
O	1551	1553	to
O	1554	1561	provide
O	1562	1563	a
O	1564	1572	stronger
O	1573	1581	position
O	1582	1586	that
O	1587	1592	there
O	1593	1595	is
O	1596	1598	no
O	1599	1606	benefit
O	1607	1609	to
O	1610	1615	using
O	1616	1626	anesthetic
O	1627	1632	cream
O	1633	1636	for
O	1637	1641	this
O	1642	1651	procedure
O	1651	1652	.
